Court rules against drug price cuts

The Seoul Administrative Court ruled last week that a 20-percent price cut on drugs of Dong-A Pharma and Hutecs Korea could be justified due to insufficient evidencing data.

Turning down a claim from the Ministry of Health and Welfare, the court said that the ministry should judge a rule which slashes the price of a drug by up to 20 percent based on the actual figures, although its producers...